What role does Pharmakogenetik Medicheck play in Wechseljahre?

The role of pharmacogenetics (Medicheck) in menopause cannot be directly answered from the provided context. Neither the product 'Pharmakogenetik Medicheck' nor its specific application in menopause is mentioned in the given sources. In general, pharmacogenetics can help optimize medication selection and dosing for hormone replacement therapy (HRT), antidepressants, or bone-protective drugs by analyzing genetic variants in drug-metabolizing enzymes (e.g., CYP450). However, evidence for routine use in menopause is limited – no large randomized trials clearly demonstrate benefit. The MyBody-X tests described in the context focus on nutrition, microbiome, and general DNA markers; no specific pharmacogenetic guidance for menopause is outlined. Therefore, the evidence level for such a test in menopause is 'unclear'. Important: pharmacogenetics does not replace clinical judgment; any medication changes must be discussed with a physician.